Predictors of late mortality among survivors by Multivariable Cox analysis with time starting on discharge date and backward stepwise variables selection including each complication individually (Schoenfeld test P = 0.57)
| Variables . | P-value; HR (95% lower, 95% upper) . |
|---|---|
| Age (years) | <0.001; 1.08 (1.05, 1.10) |
| Gender male | 0.001; 1.27 (1.10, 1.47) |
| NYHA III–IV | 0.12; 1.19 (0.97, 1.29) |
| Previous myocardial infarction | <0.001; 1.45 (1.16, 1.80) |
| Extracardiac arteriopathy | <0.001; 1.69 (1.33, 2.16) |
| LVEF <30% | 0.12; 1.25 (0.94, 1.66) |
| CPB time (min) | 0.016; 1.005 (1.001–1.010) |
| Cross-clamp time (min) | 0.011; 0.992 (0.986, 0.998) |
| Operation date (2010–2019 reference) | |
| 2000–2009 | 0.037; 1.25 (1.08, 1.45) |
| Postoperative cerebral stroke | <0.001; 2.75 (1.69, 4.46) |
| Renal replacement therapy | 0.075; 1.65 (0.95, 2.87) |
| Variables . | P-value; HR (95% lower, 95% upper) . |
|---|---|
| Age (years) | <0.001; 1.08 (1.05, 1.10) |
| Gender male | 0.001; 1.27 (1.10, 1.47) |
| NYHA III–IV | 0.12; 1.19 (0.97, 1.29) |
| Previous myocardial infarction | <0.001; 1.45 (1.16, 1.80) |
| Extracardiac arteriopathy | <0.001; 1.69 (1.33, 2.16) |
| LVEF <30% | 0.12; 1.25 (0.94, 1.66) |
| CPB time (min) | 0.016; 1.005 (1.001–1.010) |
| Cross-clamp time (min) | 0.011; 0.992 (0.986, 0.998) |
| Operation date (2010–2019 reference) | |
| 2000–2009 | 0.037; 1.25 (1.08, 1.45) |
| Postoperative cerebral stroke | <0.001; 2.75 (1.69, 4.46) |
| Renal replacement therapy | 0.075; 1.65 (0.95, 2.87) |
HR: hazard ratio.
Predictors of late mortality among survivors by Multivariable Cox analysis with time starting on discharge date and backward stepwise variables selection including each complication individually (Schoenfeld test P = 0.57)
| Variables . | P-value; HR (95% lower, 95% upper) . |
|---|---|
| Age (years) | <0.001; 1.08 (1.05, 1.10) |
| Gender male | 0.001; 1.27 (1.10, 1.47) |
| NYHA III–IV | 0.12; 1.19 (0.97, 1.29) |
| Previous myocardial infarction | <0.001; 1.45 (1.16, 1.80) |
| Extracardiac arteriopathy | <0.001; 1.69 (1.33, 2.16) |
| LVEF <30% | 0.12; 1.25 (0.94, 1.66) |
| CPB time (min) | 0.016; 1.005 (1.001–1.010) |
| Cross-clamp time (min) | 0.011; 0.992 (0.986, 0.998) |
| Operation date (2010–2019 reference) | |
| 2000–2009 | 0.037; 1.25 (1.08, 1.45) |
| Postoperative cerebral stroke | <0.001; 2.75 (1.69, 4.46) |
| Renal replacement therapy | 0.075; 1.65 (0.95, 2.87) |
| Variables . | P-value; HR (95% lower, 95% upper) . |
|---|---|
| Age (years) | <0.001; 1.08 (1.05, 1.10) |
| Gender male | 0.001; 1.27 (1.10, 1.47) |
| NYHA III–IV | 0.12; 1.19 (0.97, 1.29) |
| Previous myocardial infarction | <0.001; 1.45 (1.16, 1.80) |
| Extracardiac arteriopathy | <0.001; 1.69 (1.33, 2.16) |
| LVEF <30% | 0.12; 1.25 (0.94, 1.66) |
| CPB time (min) | 0.016; 1.005 (1.001–1.010) |
| Cross-clamp time (min) | 0.011; 0.992 (0.986, 0.998) |
| Operation date (2010–2019 reference) | |
| 2000–2009 | 0.037; 1.25 (1.08, 1.45) |
| Postoperative cerebral stroke | <0.001; 2.75 (1.69, 4.46) |
| Renal replacement therapy | 0.075; 1.65 (0.95, 2.87) |
HR: hazard ratio.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
